Literature DB >> 26089724

Quality of life of nasopharyngeal cancer survivors in China.

J S Hong1, J Tian2, Q F Han1, Q Y Ni2.   

Abstract

PURPOSE: We assessed the quality of life (qol) of nasopharyngeal carcinoma (npc) survivors with a survival time of more than 2 years in Fujian, China, and we analyzed factors influencing qol.
METHODS: We calculated the prevalence of psychological distress and radiotherapy (rt)-induced symptoms in 216 npc survivors who participated in a cross-sectional survey. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (version 3.0) was used to assess the qol of npc survivors. Multiple linear regression was applied to analyze the factors influencing qol.
RESULTS: The prevalence rates of rt-induced symptoms and psychological problems were 11.58% (95% ci: 7.21% to 15.58%) for difficulty in swallowing, 17.59% (95% ci: 12.51% to 22.67%) for mouth dryness or sores, 13.89% (95% ci: 9.28% to 18.50%) for nasal dryness or congestion, 18.52% (95% ci: 13.34% to 23.70%) for fatigue, 11.11% (95% ci: 6.92% to 15.30%) for frequent dizziness, 18.06% (95% ci: 12.93% to 23.19%) for decline in hearing, 14.81% (95% ci: 10.07% to 19.55%) for poor sleep quality, 18.52% (95% ci: 13.34% to 23.70%) for worry about disease recurrence, 18.98% (95% ci: 13.75% to 24.21%) for anxiety, and 25.00% (95% ci: 19.23% to 30.77%) for depression. Mean survival times were 4.32 ± 2.63 years in patients with mouth dryness or sores, 4.26 ± 2.90 years in patients with fatigue, and 5.60 ± 2.94 years in patients with a decline in hearing. The mean global qol score was 74.21 (95% ci: 72.22 to 76.20). At a significance level of α = 0.05, the factors influencing qol were age (p = 0.032), education level (p = 0.001), anxiety score (p < 0.001), depression score (p < 0.001), mouth dryness or sores (p < 0.001), fatigue (p = 0.027), and disease stage (p = 0.044).
CONCLUSIONS: The prevalence rates of mouth dryness or sores, fatigue, decline in hearing, depression, and anxiety were high in npc survivors with a survival time of more than 2 years. These rt-induced symptoms and psychological problems can last for many years after rt. The qol of the npc survivors was good. Factors influencing qol were age, education level, anxiety, depression, mouth dryness or sores, fatigue, and disease stage. Our results suggest that during clinical treatment, doctors should minimize the radiation dose to the ears of patients. In addition, our results emphasize the importance of providing oral and ear nursing and psychological care to npc survivors.

Entities:  

Keywords:  Nasopharyngeal cancer; anxiety; depression; quality of life; side effects

Year:  2015        PMID: 26089724      PMCID: PMC4462535          DOI: 10.3747/co.22.2323

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  37 in total

Review 1.  The causes and consequences of cancer-associated malnutrition.

Authors:  Eric Van Cutsem; Jann Arends
Journal:  Eur J Oncol Nurs       Date:  2005       Impact factor: 2.398

Review 2.  Cancer and the mind. Maudsley Bequest Lecture delivered before the Royal College of Psychiatrists, February 1983.

Authors:  S Greer
Journal:  Br J Psychiatry       Date:  1983-12       Impact factor: 9.319

Review 3.  Managing the adverse effects of radiation therapy.

Authors:  Franklin J Berkey
Journal:  Am Fam Physician       Date:  2010-08-15       Impact factor: 3.292

4.  Quality of life of nasopharyngeal carcinoma patients.

Authors:  Yoav P Talmi; Zeev Horowitz; Lev Bedrin; Michael Wolf; Gavriel Chaushu; Jona Kronenberg; M Raphael Pfeffer
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

5.  Physical distress, emotional status, and quality of life in patients with nasopharyngeal cancer complicated by post-radiotherapy endocrinopathy.

Authors:  Bee-Horng Lue; Tien-Shang Huang; Hsiu-Jung Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-08-31       Impact factor: 7.038

Review 6.  Cancer-related fatigue: the scale of the problem.

Authors:  Maarten Hofman; Julie L Ryan; Colmar D Figueroa-Moseley; Pascal Jean-Pierre; Gary R Morrow
Journal:  Oncologist       Date:  2007

Review 7.  Pain and neuropathy in cancer survivors. Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment.

Authors:  Rosemary C Polomano; John T Farrar
Journal:  Am J Nurs       Date:  2006-03       Impact factor: 2.220

8.  Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment.

Authors:  Fu-Min Fang; Herng-Chia Chiu; Wen-Rei Kuo; Chong-Jong Wang; Stephen W Leung; Hui-Chun Chen; Li-Min Sun; Hsuan-Chih Hsu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

Review 9.  Cancer-related fatigue and its associations with depression and anxiety: a systematic review.

Authors:  Linda F Brown; Kurt Kroenke
Journal:  Psychosomatics       Date:  2009 Sep-Oct       Impact factor: 2.386

10.  Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. A cross-cultural perspective.

Authors:  C M Leung; S Ho; C S Kan; C H Hung; C N Chen
Journal:  Int J Psychosom       Date:  1993
View more
  16 in total

1.  β-Catenin is important for cancer stem cell generation and tumorigenic activity in nasopharyngeal carcinoma.

Authors:  Rui Jiang; Xiaoshuang Niu; Yuxiang Huang; Xiaosheng Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-04       Impact factor: 3.848

2.  Factors influencing the health-related quality of life of Chinese advanced cancer patients and their spousal caregivers: a cross-sectional study.

Authors:  Qiuping Li; Yinghua Xu; Huiya Zhou; Alice Yuen Loke
Journal:  BMC Palliat Care       Date:  2016-08-02       Impact factor: 3.234

3.  Revalidation of a prognostic score model based on complete blood count for nasopharyngeal carcinoma through a prospective study.

Authors:  Xiaohui Li; Hui Chang; Yalan Tao; Xiaohui Wang; Jin Gao; Wenwen Zhang; Chen Chen; Yunfei Xia
Journal:  Chin J Cancer Res       Date:  2016-10       Impact factor: 5.087

4.  Efficacy and Safety of Chemotherapy Combined with Stereotactic Radiotherapy in the Treatment of Nasopharyngeal Carcinoma.

Authors:  Guo-Ping Shan; Bing-Bing Wang; Peng Zheng; Feng-Lei Du; Yi-Wei Yang
Journal:  Med Sci Monit       Date:  2017-11-26

5.  RSF1 regulates the proliferation and paclitaxel resistance via modulating NF-κB signaling pathway in nasopharyngeal carcinoma.

Authors:  Yong Liu; Guo Li; Chao Liu; Yaoyun Tang; Shuai Zhang
Journal:  J Cancer       Date:  2017-02-09       Impact factor: 4.207

Review 6.  Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors.

Authors:  Lachlan McDowell; June Corry; Jolie Ringash; Danny Rischin
Journal:  Front Oncol       Date:  2020-06-12       Impact factor: 6.244

7.  Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.

Authors:  Xiaojiao Zeng; Guohong Liu; Yunbao Pan; Yirong Li
Journal:  J Cell Mol Med       Date:  2020-06-30       Impact factor: 5.310

8.  The psychological status in patients with nasopharyngeal carcinoma during radiotherapy.

Authors:  Caihong Wang; Jinmei Chen; Li Su; Yangjingling Hua; Jinru Ye; Xiurong Song; Wenlong Lv; Mingwei Zhang; Fei Huang; Jun Tian; Jinsheng Hong
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-10       Impact factor: 2.503

9.  Spatiotemporal dynamics of γH2AX in the mouse brain after acute irradiation at different postnatal days with special reference to the dentate gyrus of the hippocampus.

Authors:  Feng Ru Tang; Lian Liu; Hong Wang; Kimberly Jen Ni Ho; Gautam Sethi
Journal:  Aging (Albany NY)       Date:  2021-06-23       Impact factor: 5.682

10.  Chibby suppresses aerobic glycolysis and proliferation of nasopharyngeal carcinoma via the Wnt/β-catenin-Lin28/let7-PDK1 cascade.

Authors:  Cheng-Fu Cai; Guo-Dong Ye; Dong-Yan Shen; Wei Zhang; Mao-Li Chen; Xin-Xin Chen; Da-Xiong Han; Yan-Jun Mi; Qi-Cong Luo; Wang-Yu Cai; Shu-Yu Yang
Journal:  J Exp Clin Cancer Res       Date:  2018-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.